Transplantation of Human Eye Allografts (THEA)
Agency: Advanced Research Projects Agency for Health
- 93.384 -- ADVANCED RESEARCH PROJECTS AGENCY for HEALTH (ARPA-H)
Archived opportunityLast Updated: May 13, 2026
View version history on Grants.gov
Description
23 Feb 2024 - The purpose of this amendment is to extend the Full Proposal due date to 25 April 2024 at 5:00PM EDT and to provide the cost proposal worksheets.
16 Feb 2024 - The purpose of this amendment is to provide the Final ISO.
The Advanced Research Projects Agency for Health (ARPA-H) posts this funding opportunity in support of the Transplantation of Human Eye Allografts (THEA) Program. ARPA-H anticipates multiple awards and award types will result from this announcement.
ARPA-H will host a Proposer's Day on February 15, 2024. The event will allow for both in-person and virtual participation and is intended to facilitate teaming and foster a greater understanding of the THEA Program. The closing date for registration is February 5, 2024, 12:00 PM EDT. In-person attendance is first-come, first-served or when capacity is reached. After reviewing the Proposers' Day information, interested parties are encouraged to register at
https://arpa-h-thea.powerappsportals.us/
Interested parties are invited to review the attached THEA Innovative Solutions Opening (ISO) 75N99224R0002.
Eligibility
Eligible applicants
Miscellaneous
- Unrestricted
Additional information
Grantor contact information
Description
THEA Program Team
Documents
No documents are currently available.
Link to additional information
Archived: May 25, 2024
Award
$--
Program Funding
--
Expected awards
$--
Award Minimum
$--
Award Maximum
Funding opportunity number:
75N99224R0002
Cost sharing or matching requirement:
Funding instrument type:
Cooperative agreement
Other
Opportunity Category:
Discretionary
Opportunity Category Explanation:
Category of Funding Activity:
Science technology and other research and development
Category Explanation:
History
Version:
4
Posted date:
January 17, 2024
Archive date:
May 25, 2024
